Cyclosporine a (CsA) treatment of chronic autoimune-mediated keratocon junctivitis sica in dogs

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

The paper is a five year retrospective study of the efficacy of 0.2% Cyclosporine A eye cream in the treatment of chronic autoimmunemediated KCS in dogs. 114 dogs of 32 breeds, both sexes, and different ages with chronic autoimmune-mediated KCS were treated with 0.2% Cyclosporine A in the form of eye cream (Optimmune®, Schering - Plough Animal Health) applied to the lower lid conjunctiva at a dose of 6 mm length of the cream strip every 12 hours, during 90 days. Dogs treated with CsA had an improved STT score, specially dogs which had STT values >5 mm/min at the start. Improvement of the clinical picture and healing of superficial corneal lesions were also recorded.

Cite

CITATION STYLE

APA

Hadži Milić, M., Jelena, D., & Krstić, N. (2013). Cyclosporine a (CsA) treatment of chronic autoimune-mediated keratocon junctivitis sica in dogs. Acta Veterinaria, 63(5–6), 677–685. https://doi.org/10.2298/AVB1306677H

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free